< Back

'diabetes mellitus, type 2'
Run an advanced search on this term

Search within:  

Sort results by:      



1-20 of 208   Next >
 
1.  
Clinical practice guideline: screening children and adolescents for type 2 diabetes mellitus in primary care. 2011 May. NGC:008586
University of Texas at Austin School of Nursing, Family Nurse Practitioner Program - Academic Institution. View all guidelines by the developer(s)
2.  
3.  
Management of type 2 diabetes mellitus. 1996 May (revised 2012 Sep). NGC:009416
University of Michigan Health System - Academic Institution. View all guidelines by the developer(s)
4.  
Liraglutide for the treatment of type 2 diabetes mellitus. 2010 Oct. NGC:008295
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
5.  
Diagnosis and management of type 2 diabetes mellitus in adults. 1996 Mar (revised 2014 Jul). NGC:010548
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
7.  
Clinical practice guideline for diabetes mellitus type 1. 2012 May 1. NGC:010282
Basque Office for Health Technology Assessment, Osteba - State/Local Government Agency [Non-U.S.]; GuiaSalud - National Government Agency [Non-U.S.]; Ministry of Health (Spain) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
8.  
Clinical practice guideline for type 2 diabetes. 2008 Jul 1 (reaffirmed 2013 Jun). NGC:009014
Basque Office for Health Technology Assessment, Osteba - State/Local Government Agency [Non-U.S.]; GuiaSalud - National Government Agency [Non-U.S.]; Ministry of Health (Spain) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes. 2012 Feb. NGC:009078
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
10.  
Dapagliflozin in combination therapy for treating type 2 diabetes. 2013 Jun. NGC:009946
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11.  
12.  
Diabetes (type 1 and type 2) in children and young people: diagnosis and management. 2004 Sep (revised 2015 Aug 26). NGC:010782
National Collaborating Centre for Women's and Children's Health - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
13.  
Empagliflozin in combination therapy for treating type 2 diabetes. 2015 Mar. NGC:010695
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
14.  
Diabetes (type 1, 2, and gestational). 2013 Sep 5. NGC:010127
Work Loss Data Institute - For Profit Organization. View all guidelines by the developer(s)
15.  
Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes. 2010 Aug (revised 2013 Jul). NGC:009997
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
16.  
Recommendations on screening for type 2 diabetes in adults. 1994 (revised 2012 Oct 16). NGC:009362
Canadian Task Force on Preventive Health Care - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17.  
Evidence-based clinical practice guideline: eye care of the patient with diabetes mellitus. 1993 (revised 2014). NGC:010318
American Optometric Association - Professional Association. View all guidelines by the developer(s)
18.  
Gestational diabetes mellitus. 2001 Sep (revised 2013 Aug). NGC:009969
American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by the developer(s)

View associated Guideline Synthesis
19.  
Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. 1996 (revised 2014 Mar 18). NGC:010198
U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)

View associated Guideline Synthesis
1-20 of 208   Next >